STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities:
Net Income (Loss)	$ (54,756)	$ (44,099)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	1,151	1,226
Provision for expected credit losses	70	46
Stock-based compensation expense	6,384	5,658
Provision for excess and obsolete inventory	(636)	(58)
Change in fair value of warrant liabilities	13,412	9,958
Accretion of discount on short-term investments	(2,905)	(747)
Amortization of operating lease right-of-use asset	1,132	865
Loss on disposal of property and equipment	23	11
Changes in operating assets and liabilities:
Accounts receivable	(7,618)	(4,494)
Inventories	(11,439)	(1,187)
Prepaid expenses and other current assets	(2,849)	(391)
Other long-term assets	(29)	(28)
Accounts payable	1,515	716
Accrued expenses and other current liabilities	6,838	1,825
Funded R&D liability-related party		(1,140)
Operating lease liability	(1,023)	(948)
Deferred revenue	2,457	342
Net cash used in operating activities	(48,273)	(32,445)
Cash flows from investing activities:
Purchases of short-term investments	(72,131)	(69,295)
Proceeds from maturities and redemptions of short-term investments	72,000
Proceeds on disposal of property and equipment	50	4
Purchases of property and equipment	(3,395)	(402)
Net cash used in investing activities	(3,476)	(69,693)
Cash flows from financing activities:
Proceeds from the issuance of convertible preferred stock, net of issuance costs	59,660	101,000
Payments for deferred offering costs	(4,147)
Proceeds from stock option exercises	89	10
Proceeds from common stock warrants exercise	13	19
Net cash provided by financing activities	55,615	101,029
Net increase (decrease) in cash, cash equivalents and restricted cash	3,866	(1,109)
Cash, cash equivalents and restricted cash at beginning of year	26,666	27,775
Cash, cash equivalents and restricted cash at end of year	30,532	26,666
Supplemental disclosure of non-cash investing and financing information:
Purchases of property and equipment included in accounts payable	129	20
Deferred offering costs included in accrued expenses and other current liabilities	862
Deferred offering costs included in accounts payable	42
Unrealized gain (loss) on short-term investments	(72)	137
Common B warrants issued in connection with Series D convertible preferred stock		22,321
Supplemental disclosure of cash flow information:
Operating lease right-of-use asset obtained in exchange for operating lease obligations	4,055	1,038
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents	30,432	26,566
Restricted cash	100	100
Total cash, cash equivalents and restricted cash shown in the statement of cash flows	$ 30,532	$ 26,666